Delivery Order SPE2DB22D1106-SPE2DB25FEBS1
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,408.14, is a Delivery Order for the supply of VALSARTAN-HCTZ 160-12.5 MG TAB 90S, a cardiovascular medication. The contract has an ultimate completion date of December 10, 2024, and is a Firm Fixed Price contract. This award is not associated with a set-aside program. In addition to this...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,129.42, is for the delivery of VALSARTAN-HCTZ 320-25 MG TAB 90S, a pharmaceutical product. The contract is a delivery order with a firm fixed price pricing type and has an ultimate completion date of April 2, 2025. The contract is not set aside for any specific business type. AmerisourceBergen...
- This federal contract award, valued at $8,014.02, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VALSARTAN-HCTZ 320-12.5 MG TAB 90S, a cardiovascular medication, to support military healthcare programs. The contract is a Firm Fixed Price Delivery Order with a completion date of January 14, 2025. This award is associated with a larger Indefinite Delivery...
- This is a $4,618.49 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of VALSARTAN-HCTZ 320-25 MG TAB 90S, a cardiovascular medication, with a period of performance through March 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a comprehensive range of...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,872.05, is for the delivery of 4563133488 - VALSARTAN-HCTZ 80-12.5 MG TAB 90S, a cardiovascular medication. The contract is a firm fixed-price, delivery order type and has an ultimate completion date of December 19, 2023. The contract is not designated with a set-aside....
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $17,622.61, is for the delivery of VALSARTAN-HCTZ 320-25 MG TAB 90S, a medication used to treat high blood pressure. The contract has a completion date of July 1, 2024 and is a firm fixed-price delivery order. There is no set-aside designation for this award. Amerisourcebergen holds a significant...
- This is a $10,171.64 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VALSARTAN-HCTZ 320-25 MG TAB 90S, a cardiovascular medication, with a period of performance through March 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $9,597.58, is for a delivery order to supply VALSARTAN-HCTZ 160-25 MG TAB 90S, a cardiovascular medication, to support federal healthcare programs. The contract has a firm fixed price and an ultimate completion date of December 3, 2024. This award is part of a larger Indefinite Delivery Contract (IDC)...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,351.98, is for the delivery of Valsartan-HCTZ 320-25 mg tablets. It is a firm-fixed price delivery order contract with an ultimate completion date of April 2, 2025. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen Drug Corp holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,107.24 delivery order contract is for the supply of VALSARTAN-HCTZ 320-12.5 MG TAB 90S, a cardiovascular medication. The contract has a firm fixed price pricing type and an ultimate completion date of May 22, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FEBS1Delivery Order
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $22,603.51, is for the delivery of VALSARTAN-HCTZ 320-25 MG TAB 90S, a cardiovascular medication. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of March 6, 2025. The contract is not designated with any set-aside requirements, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $22.6k | 3/5/25 |